Archive

Discover the implications of SA’s missing middle, where rising medical scheme costs leave many without adequate healthcare options.

GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends.

Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa’s local manufacturing goals.

South Africa’s Lenacapavir rollout begins on June 5, 2026, offering a new HIV prevention tool in high-burden districts.

Discover the benefits of the Africa Vaccine Procurement Framework for vaccine manufacturing and demand aggregation in Africa.

Biovac’s expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May.

German Drug Price Reforms aim to plug a €40bn health insurance gap by 2030, tightening rebates, reimbursements and hospital funding.

AI diagnostic tools are revolutionising healthcare. A South African study shows these systems outperform doctors at a fraction of the cost.

Dis-Chem Health Hub debuts, combining clinics, pharmacy, telehealth and insurance to cut costs and improve access.

GEMS 2026 Contribution Increase drops to 7.5% from 1 July, easing pressure on public servants as the scheme targets costs and fraud.

The Zimbabwe National Health Strategy 2026-2030 outlines a transformative roadmap for enhancing health and well-being nationwide.